NCT06624085
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06624085
Title A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California Los Angeles (UCLA) - Cancer Care - Santa Monica Santa Monica California 90404-2023 United States Details
AdventHealth Cancer Institute Orlando Florida 32804 United States Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Kansas City VA Medical Center Kansas City Kansas 64128 United States Details
Stony Brook Univ Cancer Ctr Stony Brook New York 11794 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Baylor College of Medicine Houston Texas 77030 United States Details
Renovatio Clinical The Woodlands Texas 77380 United States Details
Auxilio Mutuo Cancer Center San Juan 00917 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field